Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) YoY Rev. per Sh. Growth : 24.52% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Guizhou Bailing Group Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was 24.52%.

Guizhou Bailing Group Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥1.03.

Guizhou Bailing Group Pharmaceutical Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for Guizhou Bailing Group Pharmaceutical Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Bailing Group Pharmaceutical Co YoY Rev. per Sh. Growth Chart

Guizhou Bailing Group Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-7.18

10.57

-5.74

21.70

20.65

Guizhou Bailing Group Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															46.03	61.96	9.65	-4.40	24.52

Guizhou Bailing Group Pharmaceutical Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Guizhou Bailing Group Pharmaceutical Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(3.085	-	2.557)	/	\| 2.557 \|
=	20.65 %

Guizhou Bailing Group Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=	(Revenue per Share (Q: Mar. 2024 )	-	Revenue per Share (Q: Mar. 2023 ))	/	\| Revenue per Share (Q: Mar. 2023 )) \|
=	(1.031	-	0.828)	/	\| 0.828 \|
=	24.52 %

Guizhou Bailing Group Pharmaceutical Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » YoY Rev. per Sh. Growth

Traded in Other Exchanges

N/A

Address

Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000

Website

http://www.gzbl.com

Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.

Executives

Jiang Wei	Director
Jiang Yong	Directors, executives
Chen Pei	Directors, executives
Kuang Xun Hua	Director
Niu Min	Directors, Directors, and Executives
Chen Zhi	Securities Affairs Representative
Zheng Rong	Executives
Li Qiang	Supervisors
Xia Wen	Supervisors
Wang Xiao Dong	Supervisors
Teng Chun Jie	Supervisors
Li Hui Fang	Supervisors
Zhang Jin Fen	Director
Cai Shou Xian	Executives

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Headlines

No Headlines